Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Paediatric Acute Leukaemia”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Early research (Phase 1)Study completedNCT01196013
What this trial is testing

Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukemia
Genzyme, a Sanofi Company 7
Testing effectiveness (Phase 2)Study completedNCT02074657
What this trial is testing

"LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia

Who this might be right for
Relapsed/Refractory Paediatric Acute Leukaemia
Hospital Universitario La Paz 13
Testing effectiveness (Phase 2)Study completedNCT00930098
What this trial is testing

A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukemia
Genzyme, a Sanofi Company 74
Testing effectiveness (Phase 2)Looking for participantsNCT07387926
What this trial is testing

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)UnknownNCT03467256
What this trial is testing

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia, Pediatric
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 18
Testing effectiveness (Phase 2)Ended earlyNCT00439296
What this trial is testing

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Who this might be right for
Recurrent Pediatric ALLRelapsed Pediatric ALLAcute Lymphoblastic Leukemia+1 more
Therapeutic Advances in Childhood Leukemia Consortium 9
Testing effectiveness (Phase 2)Ended earlyNCT03705507
What this trial is testing

International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, AdultAcute Lymphoblastic Leukemia, Pediatric+2 more
University of Birmingham 12
Testing effectiveness (Phase 2)Ended earlyNCT02227108
What this trial is testing

Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

Who this might be right for
B-Cell Pediatric ALL
MedImmune LLC 37
Early research (Phase 1)Study completedNCT02808442
What this trial is testing

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

Who this might be right for
Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic Leukemia
Institut de Recherches Internationales Servier 13
Testing effectiveness (Phase 2)Study completedNCT03289455
What this trial is testing

CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRefractory Childhood Acute Lymphoblastic Leukemia+1 more
Autolus Limited 23
Testing effectiveness (Phase 2)Study completedNCT00440726
What this trial is testing

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 31